FATE

NASDAQStock

Fate Therapeutics, Inc.

$1.19-0.04 (-3.66%)

52-Week Range

$0.68

$1.67

Key Stats

Market Cap

137.8M

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.23

Volume

739.4K

Avg Volume

1.6M

Performance

+0.00%

+4.46%

+22.41%

YTD

+18.61%

+24.01%

-78.65%

-98.74%

Price Chart

ETF Exposure

FATE is held by 36 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
CNCR	Loncar Cancer Immunotherapy ETF	3.33%	17,661	$894K	$12.7M	0.79%
JFWD	Jacob Forward ETF	0.88%	902	$0	$2.4M	0.75%
HTEC	ROBO Global Healthcare Technology and Innovation ETF	0.56%	29,464	$0	$49.6M	0.68%
QQQS	Invesco NASDAQ Future Gen 200 ETF	0.54%	57,948	$75K	$13.8M	0.20%
WDNA	WisdomTree BioRevolution Fund	0.23%	4,093	$5K	$2.3M	0.45%
STSB	iShares Factors US Small Blend Style ETF	0.19%	176	$12K	$7.3M	0.35%
JHMH	John Hancock Multifactor Health Care ETF	0.10%	548	$49K	$20.3M	0.40%
IWC	iShares Micro-Cap ETF	0.03%	282,260	$364K	$1.27B	0.60%
PRFZ	Invesco RAFI US 1500 Small-Mid ETF	0.01%	299,090	$386K	$2.67B	0.34%
IWN	iShares Russell 2000 Value ETF	0.01%	907,033	$1.2M	$12.45B	0.24%
VTWV	Vanguard Russell 2000 Value ETF	0.01%	74,433	$89K	$1.00B	0.06%
RSSL	Global X - Russell 2000 ETF	0.01%	51,509	$78K	$1.38B	0.08%
IWM	iShares Russell 2000 ETF	0.01%	2,584,878	$3.3M	$70.17B	0.19%
VTWO	Vanguard Russell 2000 ETF	0.00%	517,622	$616K	$14.50B	0.06%
SCHA	Schwab U.S. Small-Cap ETF	0.00%	515,325	$665K	$20.05B	0.04%
URTY	ProShares - UltraPro Russell2000	0.00%	6,505	$8K	$309.0M	1.08%
UWM	ProShares - Ultra Russell2000	0.00%	6,554	$8K	$264.2M	1.07%
DFAT	Dimensional - US Targeted Value ETF	0.00%	157,404	$203K	$12.61B	0.28%
VHT	Vanguard Health Care ETF	0.00%	296,746	$353K	$19.80B	0.09%
HDG	ProShares - Hedge Replication ETF	0.00%	121	$156	$23.2M	0.95%
SMMD	iShares Russell 2500 ETF	0.00%	38,597	$50K	$2.33B	0.23%
VXF	Vanguard Extended Market ETF	0.00%	1,069,647	$1.3M	$84.10B	0.05%
DFAU	Dimensional - US Core Equity Market ETF	0.00%	15,455	$20K	$10.55B	0.12%
DFUS	Dimensional - US Equity Market ETF	0.00%	14,579	$19K	$18.80B	0.09%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	9	$11	$61.4M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	30	$38	$81.5M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	51	$65	$81.7M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	59	$75	$64.1M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	69	$89	$59.0M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	58	$74	$42.9M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	38	$49	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	29	$37	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	13	$16	$9.5M	0.12%
IWV	iShares Russell 3000 ETF	0.00%	20,397	$26K	$17.58B	0.20%
VTHR	Vanguard Russell 3000 ETF	0.00%	8,193	$10K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	2,974,111	$3.5M	$2.10T	0.03%

About FATE ETF Exposure

Fate Therapeutics, Inc. (FATE) is held by 36 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 137.8M, FATE is a widely held institutional stock. The stock currently trades at $1.19. Investors can gain exposure to FATE through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold FATE, sorted by portfolio weight.